FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved a supplemental application for ORENCIA (abatacept) submitted by E.R. Squibb & Sons, L.L.C., indicating an approved update to the reference BLA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

SUPPL AP for ORENCIA (ABATACEPT)